Tuesday, October 20, 2026 | UTC
About | Contact | API Status
Sign In Subscribe
Live
AAPL $339.73 -0.94%
MSFT $532.13 -0.26%
GOOGL $340.24 -1.14%
AMZN $262.76 +0.12%
TSLA $373.78 +1.55%
META $694.44 -1.56%
NVDA $216.48 -0.28%
JPM $335.39 +0.56%
BTC $36.48 +0.93%
ETH $23.23 +1.82%
Latest Signing ceremony for contribution agreements between WHO and France Oct 17, 2024
AAPL
$339.73
▼ 0.94%
MSFT
$532.13
▼ 0.26%
GOOGL
$340.24
▼ 1.14%
AMZN
$262.76
▲ 0.12%
TSLA
$373.78
▲ 1.55%
META
$694.44
▼ 1.56%
NVDA
$216.48
▼ 0.28%
JPM
$335.39
▲ 0.56%

Top Stories

Markets →
All Markets Technology Economy Science Health Sports Entertainment Politics
Science Daily
Semaglutide (Ozempic) linked to fewer bone fractures despite greater weight loss
A large real-world study suggests semaglutide (Ozempic, Wegovy, Rybelsus) may offer an unexpected bonus for people with type 2 diabetes: stronger protection against bone fractures while delivering greater weight loss. Researchers analyzing health records from nearly 60,000 adults found that people taking semaglutide experienced about 15% fewer fractures than those using other common weight-loss medications, despite losing more weight.
science  Jun 16, 2026
Variety
Content Partners Secures Fresh Round of Funding From Carlyle Global Credit
Content Partners has struck a new deal with Carlyle Global Credit to facilitate fresh investment capital for the company that has been a pioneer in buying out ownership stakes and profit participation rights in movies and TV shows from individuals and production companies. Investment giant Carlyle owns the majority of Los Angeles-based Content Partners, which […]
entertainment  Jun 16, 2026

Stay ahead of the markets.

Get free access to breaking news, stock data, and market analysis.

Subscribe Free